Lucinda Y. Quan's Insider Trades & SAST Disclosures

Lucinda Y. Quan's most recent trade in Aligos Therapeutics Inc was a trade of 78,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 15, 2023.

Share

Note

This is a custom search result for pattern Lucinda Y. Quan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2023	78,750	78,750	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jul 2022	52,500	52,500	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	105,000	105,000	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	26,250	26,250	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Dec 2020	200,000	200,000	-		-	Stock Option (Right to Buy)
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks		20 Oct 2020	6,835	6,835	-		-	Common Stock
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks		20 Oct 2020	6,835	0	-		-	Series A Preferred Stock
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks		20 Oct 2020	1,697	8,532	-		-	Common Stock
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks		20 Oct 2020	1,697	0	-		-	Series B-1 Preferred Stock
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks		20 Oct 2020	726	0	-		-	Series B-2 Preferred Stock
Aligos Therapeutics Inc	Lucinda Y. Quan	See Remarks		20 Oct 2020	726	9,258	-		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades